Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis Pigmentosa

This study has been completed.

Study NCT00004827 Information provided by FDA Office of Orphan Products Development

First Received: February 24, 2000 Last Updated: May 15, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given